![Robert Macdonald](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Robert Macdonald
Chief Tech/Sci/R&D Officer at ACASTI PHARMA INC.
Net worth: - $ as of 2024-05-30
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Vimal Kumar Kavuru | M | 55 | 3 years | |
Prashant Kohli | M | 52 | 3 years | |
Robert DelAversano | M | 52 | - | |
Carrie D'Andrea | F | 52 |
Edge Therapeutics, Inc.
![]() Edge Therapeutics, Inc. BiotechnologyHealth Technology Edge Therapeutics, Inc. is clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of novel, hospital-based therapies capable of transforming treatment paradigms in the management of acute, life-threatening neurological and other conditions. Its product candidate is the EG-1962. The company was founded on January 22, 2009 by Brian A. Leuthner, Robert Loch Macdonald and Carl J. Soranno and is headquartered in Berkeley Heights, NJ. | 7 years |
Santosh Kottayil | M | - | 1 years | |
Anatol von Hahn | M | - |
St. Michael's Hospital
![]() St. Michael's Hospital Hospital/Nursing ManagementHealth Services St. Michael's Hospital engages in the provision of healthcare services. The firm operates as a Catholic teaching and research hospital. It also offers patient care services. The company was founded in 1892 and is headquartered in Toronto, Canada. | - |
A. Davis | M | 57 | 1 years | |
Bill Butt | M | 61 |
St. Michael's Hospital
![]() St. Michael's Hospital Hospital/Nursing ManagementHealth Services St. Michael's Hospital engages in the provision of healthcare services. The firm operates as a Catholic teaching and research hospital. It also offers patient care services. The company was founded in 1892 and is headquartered in Toronto, Canada. | - |
Thomas Hudson | M | 62 |
University of Toronto
| 17 years |
Nora Aufreiter | F | 64 |
St. Michael's Hospital
![]() St. Michael's Hospital Hospital/Nursing ManagementHealth Services St. Michael's Hospital engages in the provision of healthcare services. The firm operates as a Catholic teaching and research hospital. It also offers patient care services. The company was founded in 1892 and is headquartered in Toronto, Canada. | - |
Roger McIntyre | M | - |
University of Toronto
| 12 years |
Sebastian Jaimungal | M | - |
University of Toronto
| 14 years |
John Hadjigeorgiou | M | 64 |
University of Toronto
| 15 years |
Catherine Streutker | F | - |
St. Michael's Hospital
![]() St. Michael's Hospital Hospital/Nursing ManagementHealth Services St. Michael's Hospital engages in the provision of healthcare services. The firm operates as a Catholic teaching and research hospital. It also offers patient care services. The company was founded in 1892 and is headquartered in Toronto, Canada. | - |
Hai Peng Xie | M | 54 |
University of Toronto
| 9 years |
Siew Kuen Ong | M | 56 |
St. Michael's Hospital
![]() St. Michael's Hospital Hospital/Nursing ManagementHealth Services St. Michael's Hospital engages in the provision of healthcare services. The firm operates as a Catholic teaching and research hospital. It also offers patient care services. The company was founded in 1892 and is headquartered in Toronto, Canada. | 30 years |
Darryl White | M | 52 |
St. Michael's Hospital
![]() St. Michael's Hospital Hospital/Nursing ManagementHealth Services St. Michael's Hospital engages in the provision of healthcare services. The firm operates as a Catholic teaching and research hospital. It also offers patient care services. The company was founded in 1892 and is headquartered in Toronto, Canada. | - |
Molly Shoichet | M | - |
University of Toronto
| 10 years |
Julie Saccone | F | - |
St. Michael's Hospital
![]() St. Michael's Hospital Hospital/Nursing ManagementHealth Services St. Michael's Hospital engages in the provision of healthcare services. The firm operates as a Catholic teaching and research hospital. It also offers patient care services. The company was founded in 1892 and is headquartered in Toronto, Canada. | - |
Anthony Graham | M | 67 |
St. Michael's Hospital
![]() St. Michael's Hospital Hospital/Nursing ManagementHealth Services St. Michael's Hospital engages in the provision of healthcare services. The firm operates as a Catholic teaching and research hospital. It also offers patient care services. The company was founded in 1892 and is headquartered in Toronto, Canada. | - |
Anatoly Langer | M | - |
St. Michael's Hospital
![]() St. Michael's Hospital Hospital/Nursing ManagementHealth Services St. Michael's Hospital engages in the provision of healthcare services. The firm operates as a Catholic teaching and research hospital. It also offers patient care services. The company was founded in 1892 and is headquartered in Toronto, Canada. | - |
Colleen Johnston | F | 65 |
St. Michael's Hospital
![]() St. Michael's Hospital Hospital/Nursing ManagementHealth Services St. Michael's Hospital engages in the provision of healthcare services. The firm operates as a Catholic teaching and research hospital. It also offers patient care services. The company was founded in 1892 and is headquartered in Toronto, Canada. | 11 years |
J. Gordon | M | 62 |
St. Michael's Hospital
![]() St. Michael's Hospital Hospital/Nursing ManagementHealth Services St. Michael's Hospital engages in the provision of healthcare services. The firm operates as a Catholic teaching and research hospital. It also offers patient care services. The company was founded in 1892 and is headquartered in Toronto, Canada. | - |
Allan J. Reesor | M | - |
St. Michael's Hospital
![]() St. Michael's Hospital Hospital/Nursing ManagementHealth Services St. Michael's Hospital engages in the provision of healthcare services. The firm operates as a Catholic teaching and research hospital. It also offers patient care services. The company was founded in 1892 and is headquartered in Toronto, Canada. | - |
Wendy Porter | F | 71 |
St. Michael's Hospital
![]() St. Michael's Hospital Hospital/Nursing ManagementHealth Services St. Michael's Hospital engages in the provision of healthcare services. The firm operates as a Catholic teaching and research hospital. It also offers patient care services. The company was founded in 1892 and is headquartered in Toronto, Canada. | - |
Jenn Humphries | F | - |
St. Michael's Hospital
![]() St. Michael's Hospital Hospital/Nursing ManagementHealth Services St. Michael's Hospital engages in the provision of healthcare services. The firm operates as a Catholic teaching and research hospital. It also offers patient care services. The company was founded in 1892 and is headquartered in Toronto, Canada. | - |
Edward Neugeboren | M | - | 1 years | |
Doug Guzman | M | - |
St. Michael's Hospital
![]() St. Michael's Hospital Hospital/Nursing ManagementHealth Services St. Michael's Hospital engages in the provision of healthcare services. The firm operates as a Catholic teaching and research hospital. It also offers patient care services. The company was founded in 1892 and is headquartered in Toronto, Canada. | - |
Franklin Techar | M | - |
St. Michael's Hospital
![]() St. Michael's Hospital Hospital/Nursing ManagementHealth Services St. Michael's Hospital engages in the provision of healthcare services. The firm operates as a Catholic teaching and research hospital. It also offers patient care services. The company was founded in 1892 and is headquartered in Toronto, Canada. | - |
Richard Earl Waugh | M | 76 |
St. Michael's Hospital
![]() St. Michael's Hospital Hospital/Nursing ManagementHealth Services St. Michael's Hospital engages in the provision of healthcare services. The firm operates as a Catholic teaching and research hospital. It also offers patient care services. The company was founded in 1892 and is headquartered in Toronto, Canada. | - |
Michael McCain | M | 65 |
St. Michael's Hospital
![]() St. Michael's Hospital Hospital/Nursing ManagementHealth Services St. Michael's Hospital engages in the provision of healthcare services. The firm operates as a Catholic teaching and research hospital. It also offers patient care services. The company was founded in 1892 and is headquartered in Toronto, Canada. | - |
Claude Richard Lamoureux | M | 81 |
St. Michael's Hospital
![]() St. Michael's Hospital Hospital/Nursing ManagementHealth Services St. Michael's Hospital engages in the provision of healthcare services. The firm operates as a Catholic teaching and research hospital. It also offers patient care services. The company was founded in 1892 and is headquartered in Toronto, Canada. | - |
David Peterson | M | 80 |
St. Michael's Hospital
![]() St. Michael's Hospital Hospital/Nursing ManagementHealth Services St. Michael's Hospital engages in the provision of healthcare services. The firm operates as a Catholic teaching and research hospital. It also offers patient care services. The company was founded in 1892 and is headquartered in Toronto, Canada. | - |
Amresh Kumar | M | 44 | 1 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Brian Leuthner | M | 59 |
Edge Therapeutics, Inc.
![]() Edge Therapeutics, Inc. BiotechnologyHealth Technology Edge Therapeutics, Inc. is clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of novel, hospital-based therapies capable of transforming treatment paradigms in the management of acute, life-threatening neurological and other conditions. Its product candidate is the EG-1962. The company was founded on January 22, 2009 by Brian A. Leuthner, Robert Loch Macdonald and Carl J. Soranno and is headquartered in Berkeley Heights, NJ. | - |
Albert Marchio | M | 72 |
Edge Therapeutics, Inc.
![]() Edge Therapeutics, Inc. BiotechnologyHealth Technology Edge Therapeutics, Inc. is clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of novel, hospital-based therapies capable of transforming treatment paradigms in the management of acute, life-threatening neurological and other conditions. Its product candidate is the EG-1962. The company was founded on January 22, 2009 by Brian A. Leuthner, Robert Loch Macdonald and Carl J. Soranno and is headquartered in Berkeley Heights, NJ. | 4 years |
Pierre Lemieux | M | 59 | 21 years | |
Sol Barer | M | 76 |
Edge Therapeutics, Inc.
![]() Edge Therapeutics, Inc. BiotechnologyHealth Technology Edge Therapeutics, Inc. is clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of novel, hospital-based therapies capable of transforming treatment paradigms in the management of acute, life-threatening neurological and other conditions. Its product candidate is the EG-1962. The company was founded on January 22, 2009 by Brian A. Leuthner, Robert Loch Macdonald and Carl J. Soranno and is headquartered in Berkeley Heights, NJ. | 8 years |
George Babu | M | - |
University of Toronto
| 15 years |
Alexandre Pernin | M | - |
University of Toronto
| 5 years |
Marko Aleksic | M | - |
University of Toronto
| 7 years |
Roger Ferreira | M | - |
University of Toronto
| 7 years |
Isaac Blech | M | 73 |
Edge Therapeutics, Inc.
![]() Edge Therapeutics, Inc. BiotechnologyHealth Technology Edge Therapeutics, Inc. is clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of novel, hospital-based therapies capable of transforming treatment paradigms in the management of acute, life-threatening neurological and other conditions. Its product candidate is the EG-1962. The company was founded on January 22, 2009 by Brian A. Leuthner, Robert Loch Macdonald and Carl J. Soranno and is headquartered in Berkeley Heights, NJ. | - |
Larry Llaguno | M | - |
University of Toronto
| 12 years |
Eric Ng | M | - |
University of Toronto
| 7 years |
Zachary Newton | M | 40 |
University of Toronto
| 4 years |
Greg Payne | M | - |
University of Toronto
| 14 years |
Shubo Yan | M | - |
University of Toronto
| 5 years |
Thomas Schneider | M | - |
University of Toronto
| 4 years |
Scott McAuley | M | - |
University of Toronto
| 9 years |
Zachary Kotowych | M | - |
University of Toronto
| 6 years |
Joseph Mocanu | M | - |
University of Toronto
| 5 years |
Lillian Zhang | F | - |
University of Toronto
| 10 years |
David Toffoli | M | - |
University of Toronto
| 4 years |
Cory Mulvihill | M | - |
University of Toronto
| 10 years |
Zemin Liu | M | - |
University of Toronto
| 5 years |
Hashem Taha | M | - |
University of Toronto
| 8 years |
Angela Jiang | F | - |
University of Toronto
| 7 years |
Brendan Cochrane | M | - |
University of Toronto
| 7 years |
Yakun Liu | M | - |
University of Toronto
| 6 years |
Liam Ratcliffe | M | 60 |
Edge Therapeutics, Inc.
![]() Edge Therapeutics, Inc. BiotechnologyHealth Technology Edge Therapeutics, Inc. is clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of novel, hospital-based therapies capable of transforming treatment paradigms in the management of acute, life-threatening neurological and other conditions. Its product candidate is the EG-1962. The company was founded on January 22, 2009 by Brian A. Leuthner, Robert Loch Macdonald and Carl J. Soranno and is headquartered in Berkeley Heights, NJ. | 3 years |
James J. Loughlin | M | 81 |
Edge Therapeutics, Inc.
![]() Edge Therapeutics, Inc. BiotechnologyHealth Technology Edge Therapeutics, Inc. is clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of novel, hospital-based therapies capable of transforming treatment paradigms in the management of acute, life-threatening neurological and other conditions. Its product candidate is the EG-1962. The company was founded on January 22, 2009 by Brian A. Leuthner, Robert Loch Macdonald and Carl J. Soranno and is headquartered in Berkeley Heights, NJ. | - |
Robert Spiegel | M | 73 |
Edge Therapeutics, Inc.
![]() Edge Therapeutics, Inc. BiotechnologyHealth Technology Edge Therapeutics, Inc. is clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of novel, hospital-based therapies capable of transforming treatment paradigms in the management of acute, life-threatening neurological and other conditions. Its product candidate is the EG-1962. The company was founded on January 22, 2009 by Brian A. Leuthner, Robert Loch Macdonald and Carl J. Soranno and is headquartered in Berkeley Heights, NJ. | 6 years |
Krystal Nagel | F | - |
University of Toronto
| 4 years |
Anastasia Elia Akulshyna | F | - |
University of Toronto
| 9 years |
Andrew Einhorn | M | 64 |
Edge Therapeutics, Inc.
![]() Edge Therapeutics, Inc. BiotechnologyHealth Technology Edge Therapeutics, Inc. is clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of novel, hospital-based therapies capable of transforming treatment paradigms in the management of acute, life-threatening neurological and other conditions. Its product candidate is the EG-1962. The company was founded on January 22, 2009 by Brian A. Leuthner, Robert Loch Macdonald and Carl J. Soranno and is headquartered in Berkeley Heights, NJ. | 3 years |
Rosemary Crane | F | 64 |
Edge Therapeutics, Inc.
![]() Edge Therapeutics, Inc. BiotechnologyHealth Technology Edge Therapeutics, Inc. is clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of novel, hospital-based therapies capable of transforming treatment paradigms in the management of acute, life-threatening neurological and other conditions. Its product candidate is the EG-1962. The company was founded on January 22, 2009 by Brian A. Leuthner, Robert Loch Macdonald and Carl J. Soranno and is headquartered in Berkeley Heights, NJ. | 2 years |
Gene C. Mack | M | 50 |
Edge Therapeutics, Inc.
![]() Edge Therapeutics, Inc. BiotechnologyHealth Technology Edge Therapeutics, Inc. is clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of novel, hospital-based therapies capable of transforming treatment paradigms in the management of acute, life-threatening neurological and other conditions. Its product candidate is the EG-1962. The company was founded on January 22, 2009 by Brian A. Leuthner, Robert Loch Macdonald and Carl J. Soranno and is headquartered in Berkeley Heights, NJ. | 2 years |
Hussein Sunderji | M | - |
University of Toronto
| 9 years |
Grant Connor | M | - |
University of Toronto
| 4 years |
W. Middlekauff | M | 63 |
Edge Therapeutics, Inc.
![]() Edge Therapeutics, Inc. BiotechnologyHealth Technology Edge Therapeutics, Inc. is clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of novel, hospital-based therapies capable of transforming treatment paradigms in the management of acute, life-threatening neurological and other conditions. Its product candidate is the EG-1962. The company was founded on January 22, 2009 by Brian A. Leuthner, Robert Loch Macdonald and Carl J. Soranno and is headquartered in Berkeley Heights, NJ. | - |
Anders Hove | M | 58 |
Edge Therapeutics, Inc.
![]() Edge Therapeutics, Inc. BiotechnologyHealth Technology Edge Therapeutics, Inc. is clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of novel, hospital-based therapies capable of transforming treatment paradigms in the management of acute, life-threatening neurological and other conditions. Its product candidate is the EG-1962. The company was founded on January 22, 2009 by Brian A. Leuthner, Robert Loch Macdonald and Carl J. Soranno and is headquartered in Berkeley Heights, NJ. | 1 years |
Yuri Sagalov | M | - |
University of Toronto
| 5 years |
Zishu Liu | M | - |
University of Toronto
| 1 years |
James Healy | M | 59 |
Edge Therapeutics, Inc.
![]() Edge Therapeutics, Inc. BiotechnologyHealth Technology Edge Therapeutics, Inc. is clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of novel, hospital-based therapies capable of transforming treatment paradigms in the management of acute, life-threatening neurological and other conditions. Its product candidate is the EG-1962. The company was founded on January 22, 2009 by Brian A. Leuthner, Robert Loch Macdonald and Carl J. Soranno and is headquartered in Berkeley Heights, NJ. | 3 years |
Irina Skrylev | F | - |
University of Toronto
| 1 years |
Yaroslava Teslya | F | - |
University of Toronto
| 6 years |
Kurt Conti | M | 61 |
Edge Therapeutics, Inc.
![]() Edge Therapeutics, Inc. BiotechnologyHealth Technology Edge Therapeutics, Inc. is clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of novel, hospital-based therapies capable of transforming treatment paradigms in the management of acute, life-threatening neurological and other conditions. Its product candidate is the EG-1962. The company was founded on January 22, 2009 by Brian A. Leuthner, Robert Loch Macdonald and Carl J. Soranno and is headquartered in Berkeley Heights, NJ. | 8 years |
Ji Ke | M | - |
University of Toronto
| 7 years |
Tess Cameron | F | - |
University of Toronto
| 5 years |
Zi Ye Mai | M | 30 |
University of Toronto
| 4 years |
Qi Qi Mai | F | 31 |
University of Toronto
| 4 years |
Claire Fan | F | - |
University of Toronto
| 4 years |
INGRID GAHOL | F | - |
University of Toronto
| 4 years |
Jensen Tam | M | - |
University of Toronto
| 4 years |
Shvetank Jain | M | - |
University of Toronto
| 2 years |
Salman Qadir | M | - |
University of Toronto
| 5 years |
Daniel Mak | M | - |
University of Toronto
| 4 years |
Muhammad Abdi | M | - |
University of Toronto
| 3 years |
Hiu Kwan Yu | F | 35 |
University of Toronto
| 4 years |
Manar Hassan-Agha | M | - |
University of Toronto
| 4 years |
Leigh Honeywell | F | - |
University of Toronto
| 9 years |
Shawn Ghazikalaye | M | - |
University of Toronto
| 4 years |
Nauman Satti | M | - |
University of Toronto
| 2 years |
Ka Ho Yu | M | 44 |
University of Toronto
| 2 years |
Rob Kaplan | M | - |
University of Toronto
| 4 years |
Mark Liu | M | - |
University of Toronto
| 4 years |
Steven Rossi | M | 39 |
University of Toronto
| 2 years |
Robert McKay | M | - |
University of Toronto
| 4 years |
Kai Zhou | M | 29 |
University of Toronto
| 4 years |
Statistics
Country | Connections | % of total |
---|---|---|
Canada | 77 | 77.00% |
United States | 23 | 23.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Robert Macdonald
- Personal Network